¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ»êÈÄdz Ä¡·á µ¿ÃᵿÇÑÀÇ¿ø °¡±îÀÌ¿¡

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ»êÈÄdz, #¼Ûµµ»êÈÄdzġ·á, #»ý¸®Àü°¡½¿ÅëÁõ, #¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ, #»êÈÄdzġ·á, #»ý¸®Àü°¡½¿ÅëÁõÄ¡·á, #¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ, #±¸¿ùµ¿»êÈÄdz ¼Ûµµ»êÈÄdz,,¼Ûµµ»êÈÄdzġ·á,,»ý¸®Àü°¡½¿ÅëÁõ,,¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ,,»êÈÄdzġ·á,,»ý¸®Àü°¡½¿ÅëÁõÄ¡·á,,¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ,,±¸¿ùµ¿»êÈÄdz ¾È³çÇϼ¼¿ä. ¼Ûµµ»êÈÄdz ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ»êÈÄdz ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â»ý¸®Àü°¡½¿ÅëÁõ, ³­ÀÓÇѹæÄ¡·á, ½ÃÇè°ü¾Æ±â, È­ÇÐÀûÀ¯»êÇÏÇ÷, »êÈÄÅëÁõ, ´ÙÀ̾îÆ®»ý¸®ºÒ¼ø, »ý¸®Àü±¸¿ªÁú, 20´ëÀڱñÙÁ¾, ¼ÒÆļúÈĸöÁ¶¸®, ¼ø»êÇѾà, ÁúÄ­µð´ÙÁõ, ºÒÀÓÇѾà, ÀڱñÙÁ¾»ý¸®Åë, ÀÓ½ÅÁغñÇѾà, Ä­µð´ÙÁú¿°³¿»õ, Ãâ»êÇѾà, ³­ÀÓÄ¡·á, ³­ÀÓÇѾà, »ý¸®ÁÖ±âºÒ±ÔÄ¢, »ý¸®½Ä¿åÀúÇÏ, »ý¸®ÀüÁõÈıº, Àڱù°È¤, »ý¸®ÀüÁõÈıºµÎÅë, ¸¸¼ºÁú¿°, »ý¸®Àü¹è¾ÆÇÄµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ½Å°æ±ÙÀ°Àü±âÀÚ±Ø, FES, ½½¸µ¿îµ¿, Çâ±â¿ä¹ý, ÀÌħ, silver spike point, °æÇÇÀûÀü±â½Å°æÀÚ±ØÄ¡·á, °æÃßÃß³ª, ¾È¸é°èÃø¹æ¹ý¿¡ ÀÇÇÑ Ã¼Çü°Ë»ç, ºÀ¾àħ, Çѹ湰¸®¿ä¹ý, Àü±âÀÚ±ØÄ¡·á, ÇÑ·©Ä¡·á, ÆĶóÇÉ¿å, ·¹ÀÌÀú, ³Ã¿Â¿å, µµÀο¿ä¹ý, ¼öÁöħ, ¾È¸é°èÃø°Ë»ç, ¾à¹°¿ä¹ý, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê ºÎ»êÁø±¸ ¹üõ2µ¿, ¿ï»ê ³²±¸ Ȳ¼ºµ¿, °æ±â È­¼º½Ã ¿ìÁ¤À¾, °æ³² Å뿵½Ã ¿ë³²¸é, Àü³² °­Áø±º µµ¾Ï¸é, Á¦ÁÖ ¼­±ÍÆ÷½Ã Áß¹®µ¿, ºÎ»ê ¼­±¸ ºÎ¹Îµ¿1°¡, Ãæ³² ¼­Ãµ±º ºñÀθé, Àü³² °íÈﱺ ¿µ³²¸é, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ µ¿¿Ï»êµ¿, °æ³² Å뿵½Ã Å뿵¿ìü±¹»ç¼­ÇÔ, °æ±â ¿©ÁÖ±º °­Ãµ¸é, °æ³² ÀǷɱº ºÀ¼ö¸é, Àü³² ¸ñÆ÷½Ã ¹«¾Èµ¿, °­¿ø °­¸ª½Ã Æ÷³²2µ¿, °æ±â ¾çÁֽà ´ö°èµ¿, °æ³² â¿ø½Ã ÁøÇر¸ ´ëÁ×µ¿, °æºÏ ÀǼº±º ´Ü¹Ð¸é, °æ±â µ¿µÎõ½Ã »óºÀ¾Ïµ¿, Ãæ³² ¼­»ê½Ã °íºÏ¸é, °æ³² »çõ½Ã »ç³²¸é, °æºÏ °æÁֽà µµÁöµ¿, ÃæºÏ Á¦Ãµ½Ã °í¸íµ¿, ¿ï»ê ºÏ±¸ âÆòµ¿, ÀüºÏ Áø¾È±º µ¿Çâ¸é, °­¿ø µ¿Çؽà ´ë±¸µ¿, °æ³² ÇÕõ±º ´ë¾ç¸é, ÀüºÏ ¹«ÁÖ±º ¾È¼º¸é, °æ±â Àǿսà °íõµ¿, Àü³² ¸ñÆ÷½Ã Á×±³µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ»êÈÄdzġ·á ãÀ¸½Ã´Â Áß±¸, ¸Å¼Û¸é, ¿¬¼öµ¿, ¼Ûµµ±¹Á¦µµ½Ã, µµÈ­µ¿, ¿µÁ¾Çϴõµ½Ã, ¹è°ð, °¡Á¤µ¿, ¼þÀǵ¿, ³²µ¿±¸, ½ÃÈï, Áßµ¿, °¡Áµ¿, û¶ó, ºÀ´ãÀ¾, ½ÃÈ­, µ¿Ãᵿ, °ü±³µ¿, ³²±¸, ¿µÁ¾µµ, ¸¶µµ¸é, ¿¬¼ö±¸, ÀÎõ, ¼Û»ê¸é, ¼Û¸²µ¿, ÀÎõ³íÇöµ¿, Á־ȿª, ¿µÈïµµ, µ¿ÀÎõ, ¹®Çе¿, °£¼®µ¿, À²¸ñµ¿, ¼Ûµµ½Åµµ½Ã, ¼±Çе¿, µµ¸²µ¿ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. As-Sanie S, Harris RE, Napadow V, et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain 2012; 153:1006. 2. ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, et al. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010; 25:578. 3. Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-Associated Mutations in Endometriosis without Cancer. N Engl J Med 2017; 376:1835. 4. Missmer SA, Chavarro JE, Malspeis S, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 2010; 25:1528. 5. Pall M, Fridén BE, Brännström M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001; 16:1323. 6. Cibula D, Sindelka G, Hill M, et al. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum Reprod 2002; 17:76. 7. Ziaei S, Faghihzadeh S, Sohrabvand F, et al. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG 2001; 108:1181. 8. Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017; 215:220.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ»êÈÄdz Ä¡·á µ¿ÃᵿÇÑÀÇ¿ø °¡±îÀÌ¿¡""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼ÛµµÀ¯»êÈÄÇѾà ÁÖ¾ÈÇÑÀÇ¿ø ¹Ù·Î¿©±â
´ÙÀ½±Û ÀÎõÇÑÀÇ¿øÃßõ ¼ÛµµÇÑÀÇ¿ø Ãʱ⿡ °ü¸®ÇØ¿ä
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
932 ÀüÁÖ ¿¹±×¸° ÇÑÀÇ¿ø 12¿ù À̺¥Æ® 1 1,559 2022-12-09
931 ºÎ»ê´ÙÀ̾îÆ® ÇÑÀÇ¿ø - 12¿ù À̺¥Æ® ´ÙÀ̾îÆ® ÇѾà ÁÖ¹®½Ã À¯Áö±â ÇÑ´Þ.. 0 1,220 2022-12-09
930 Çã¹÷Áö±ÙÀ°»©±â ¿À´ÃºÎÅÍ ½ÃÀÛÇϼ¼¿ä 0 1,090 2022-11-15
929 ¿ï»ê »ï»êµ¿ ¿©µå¸§ Ä¡·á ÇÑÀÇ¿ø 11¿ù À̺¥Æ® °øÁö! 0 2,171 2022-11-15
928 ±Ô¸²ÇÑÀÇ¿ø 11¿ù À̺¥Æ® ¾È³» 0 836 2022-11-15
927 ºÎ»ê¼­¸éºñ¸¸ÇÑÀÇ¿ø, ÀϸÆÇÑÀÇ¿øºÎ»êÁ¡ 11¿ùÀÇ ´ÙÀ̾îÆ®ÇѾà À̺¥Æ® ½Ã.. 1 2,617 2022-11-15
926 â¿ø ¸¶»ê´ÙÀ̾îÆ®ÇÑÀÇ¿ø À¯¾Ø¹ÌÇÑÀÇ¿ø ´ÙÀ̾îƮȯ À̺¥Æ® 0 1,036 2022-10-22
925 2022, ³ì¿øÇÑÀÇ¿ø Ãß¼®¸ÂÀÌ ÇѾà À̺¥Æ® 0 898 2022-08-24
924 [³»°îµ¿ÇÑÀÇ¿ø]Ãß¼® °øÁø´Ü/°æ¿Á°í °¨»ç À̺¥Æ® 0 1,032 2022-08-24
923 û¶ó ½Å³ó¾¾ÇÑÀÇ¿ø Ãß¼®¸ÂÀÌ À̺¥Æ® 0 1,340 2022-08-24
922 ½Å»çµ¿ ½Å»ç¿ª´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¼±ÀÌ°íÀºÇÑÀÇ¿ø 8¿ù 9¿ù À̺¥Æ® 1 3,691 2022-08-08
921 ´ë¹æÇÑÀÇ¿ø 8¿ù À̺¥Æ® 0 972 2022-08-08
920 ¿ï»ê »ï»êµ¿ ¿©µå¸§ Ä¡·á ÇÑÀÇ¿ø 8¿ù À̺¥Æ® °øÁö 0 1,323 2022-08-08
919 ¼­¸é´ÙÀ̾îÆ®ÇѾà ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡, 8¿ù Áö¹æ¼ÒÅÁ À̺¥Æ® ½ÃÀÛÇß¾î¿ä 1 3,200 2022-08-08
918 ±¤ÁÖ´ÙÀ̾îÆ®ÇÑ¾à ¸ö¼ÓÀ» ±ú²ýÇÏ°Ô Çغ¼±î? 0 1,066 2022-08-04
917 ¿ï»ê´ÙÀ̾îÆ®ÇѾà 1´ë1 ¸ÂÃã ÇѾàÀ» ÅëÇØ ½ÃÀÛÇغ¸¼¼¿ä 0 972 2022-08-04
916 ÀÎõ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¿ÃÇش üÁß °¨·® ¼º°øÇÒ ¼ö ÀÖ°Ô 1 798 2022-08-04
915 ¼­¸é´ÙÀ̾îÆ®ÇÑ¾à ¹«¸®ÇÏÁö ¾Ê´Â °ÍÀÌ °¡Àå ÁÁ¾Æ¿ä 1 711 2022-08-03
914 õȣ´ÙÀ̾îÆ®ÇÑ¾à ¹Ù»Û »ýÈ° ¼Ó °£ÆíÇÏ°Ô °ü¸® ÇÒ ¼ö ÀÖ´Â ¹æ¹ý 1 689 2022-08-03
913 ¼­¸é´ÙÀ̾îÆ®ÇÑ¾à °Ç°­ÇÑ °¨·® ÁøÇàÇϱâ 1 636 2022-08-02
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷